Big
Technologies plc
("the Company" or "the
Group")
Preliminary announcement of the Group's audited results for
the year ended 31 December 2023
"Continued growth and strong cash
generation"
Big Technologies plc (AIM: BIG), the
leading, integrated technology platform for the remote monitoring
of individuals, is pleased to announce its preliminary audited
results for the year ended 31 December 2023.
£m
(unless otherwise stated)
|
Audited
2023
|
Audited
2022
|
|
|
|
Revenue
|
55.2
|
50.2
|
Gross margin (%)
|
70.7%
|
72.5%
|
Statutory operating
profit
|
16.8
|
20.6
|
Adjusted operating
profit*
|
28.2
|
27.1
|
Adjusted EBITDA*
|
33.0
|
30.5
|
Adjusted EBITDA* margin
(%)
|
59.8%
|
60.7%
|
Cash generated from operating
activities
|
31.7
|
25.7
|
Net cash
|
85.9
|
66.8
|
|
|
|
|
Pence
|
Pence
|
Adjusted diluted earnings per
share*
|
8.6p
|
8.1p
|
Adjusted basic earnings per
share*
|
9.2p
|
8.6p
|
Statutory diluted earnings per
share
|
5.7p
|
6.5p
|
Statutory basic earnings per
share
|
6.1p
|
6.9p
|
|
|
|
|
|
|
*Before adjusting items and
share-based payments
|
Financial performance
·
Double-digit organic revenue growth
of 10% driven by both new contract wins and an increase in revenues
earned from existing customers;
· Gross
margin of 70.7%, a decrease of 180 bps versus prior year as a
result of one-off charges for higher inventory provisioning and an
impairment loss recognised against other fixed assets;
· Adjusted EBITDA of £33.0 million with adjusted EBITDA margin
of 59.8%;
· Cash
generated from operating activities of £31.7 million, delivered by
the strong trading performance during the year. The Group has a
significant net cash balance of £85.9 million at the end of the
year underpinning a very strong balance sheet. Net cash is stated
after deducting £1.9 million of lease liabilities.
Operational and strategic performance
· Established an additional office in Latin America to support a
new customer in the region;
· Mobilised equipment and a team of people at very short notice
to support a new customer in the Asia-Pacific region;
· Significantly expanded business development efforts in the
United States, building a new team of sales executives and support
staff to drive growth in the country;
· Launched
Buddi substance detection technologies and finalised development of
our first body-worn alcohol detection technology, the Buddi
AlcoTag.
Current trading and outlook
· The Group has
started the new financial year in line with the Board's
expectations;
·
The Group remains
well-positioned with the financial flexibility to invest in new
technologies and has a clear strategy for business development and
investment in target markets where it is currently
under-represented;
· Future
prospects remain supported by long-term growth drivers in criminal
justice, where electronic monitoring offers a viable alternative to
incarceration;
· Despite some
short-term headwinds to sales and profits expected in 2024 as a
result of the ending of a contract in Colombia, the Group expects
to remain highly profitable and cash-generative and there is a
solid pipeline of future opportunities. The Board is confident of a
return to growth in 2025 and beyond.
Commenting on the results, Sara Murray OBE, Chief Executive
Officer said:
"In difficult market conditions,
2023 has seen the Group deliver a strong performance with continued
growth in sales, profits and our cash reserves. We continue to
invest in the business and in our market-leading suite of
monitoring products and expect to see growth in the coming years.
We are obviously disappointed with the outcome in Colombia, with a
customer that we have served well for a number of years. We see a
pipeline of attractive business opportunities around the globe and
will continue to work diligently to grow, and decrease
concentration in, our revenue stream."
For further information please
contact:
Big Technologies
|
+44 (0) 1923 601910
|
Sara Murray (Chief Executive
Officer)
Daren Morris (Chief Financial
Officer)
|
|
|
|
Zeus (Nominated Adviser and Sole
Broker)
|
+44 (0) 2038 295000
|
Dan Bate / Kieran
Russell (Investment Banking)
Benjamin Robertson (Equity Capital
Markets)
|
|
The person responsible for arranging
the release of this information is Daren Morris, Chief Financial
Officer and Company Secretary.
CEO's review
Overview
I am pleased to report that we have
delivered another strong set of results, in line with market
expectations for 2023. There was continued growth in revenues,
adjusted profits and net cash. This performance shows the strength
and resilience of our cash-generative business model against a
backdrop of persisting uncertainty in global macroeconomic
conditions. I would like to thank our teams across the globe for
their contribution to these results and their continued commitment
to our strategy of delivering innovative remote people monitoring
solutions to improve people's quality of life and make societies
safer.
Financial performance
The Group continued to deliver
double-digit organic revenue growth in the year of 10%, to £55.2m
(2022: £50.2m). The second half of the year saw revenues increase
to £27.9m for the most recent six-month period (H1 2023: £27.3m),
reflecting the contribution of new contract wins and an increase in
revenues earned from existing customers. The growth in full year
revenue was delivered by growth from customers in the criminal
justice sector, in particular those in the European and
Asia-Pacific regions.
The 2023 year saw the Group maintain
consistently strong levels of profitability from the revenue growth
demonstrating our scalable operating model. Gross margins fell by
180 bps to 70.7% (2022: 72.5%) as a result of one-off charges in
cost of sales for higher inventory provisioning for previous
generation components and an impairment loss recognised against
other fixed assets held by Buddi Colombia, linked to the ending of
a customer contract.
Adjusted EBITDA increased by 8% to
£33.0m (2022: £30.5m) with Adjusted EBITDA margin falling slightly
by 90bps to 59.8% (2022: 60.7%).
The Group generated £31.7m in cash
from operations, with the net cash position at the end of the year
being £85.9m, underpinning a very strong balance sheet.
Operations and product development
We continued to increase our
international footprint and global presence in the criminal justice
sector, with new contract wins and more feet on the ground in new
countries, whilst delivering more for existing customers, resulting
in increased revenues.
We established an additional office
in Latin America to support a new customer, which was won and
onboarded during the second half of the year and is now
contributing revenue.
We mobilised equipment and a team of
people, at very short notice, to support a new customer in the
Asia-Pacific region with a critical new programme.
We significantly expanded our
business development resources in the United States, building a new
team of sales executives and support staff, to enable engagement
with new customers in the country. The US market is the largest
market in the world for electronic monitoring and we have
historically been under-represented locally.
We were disappointed not to be
selected by the UK Ministry of Justice for the national contract to
supply electronic monitoring services in England and Wales. In this
instance, the customer chose to remain with their existing
long-term supplier primarily due to up-front cost considerations,
despite their admission of over-charging in a previous contract and
fine following investigation by the Serious Fraud Office. We
will continue to work hard to educate potential customers on the
benefits that our leading-edge technology brings.
We remain committed to ensuring that
our products maintain their competitive advantage in the criminal
justice sector and continue to invest in research and development
to support our future product roadmap. This roadmap includes the
development of a range of technologies, which meet the growing
needs of our current and potential customers. Our recent
focus has been in the area of substance detection technologies, as
well as improving and extending our range of location
solutions. This has enabled us to provide an integrated
monitoring offering for our customers and future customers, which
meets the majority of their current needs and requirements.
We finalised the development of our first real-time alcohol
detection technology, the Buddi AlcoTag, which has now entered
production and is being offered to priority customers.
Strategic priorities
Big Technologies remains focused on
its robust and stable business model, with the Board and senior
management team prioritising three key strategic imperatives for
the year ahead. These priorities will enable us to deliver
long-term value for all our stakeholders.
1) Increase US market presence
We have historically been
under-represented in the United States, which is the largest market
in the world for electronic monitoring and substance detection
technologies. We have significantly expanded our business
development efforts in the country, with additional sales
executives and support staff in place and a clear strategy to
educate customers in the benefits of newer technologies.
2) Launch Buddi substance detection
technologies
We have finalised the development of
our first body-worn alcohol detection technology, the Buddi
AlcoTag, and its supporting software. This solution is now being
offered to priority customers. It combines our proven Smart Tag®
location and communication technologies with real-time alcohol
detection, delivering the world's first combined tag. The
subject of a number of patents, it has several advanced features,
improving upon industry standard devices, which only provide
location or alcohol detection. It is no longer necessary for
any individual to wear a tag on each leg, when subject to both
alcohol abstinence and location monitoring court orders.
3) Pursue acquisitions and
partnerships
We are well positioned, with the
financial resources in place, to invest in the right
value-enhancing acquisitive growth opportunities. We will continue
to actively seek partners in the Americas region, who can help us
access these promising markets. We believe that enhancing our local
presence, and routes to market, will enable us to scale the
business more quickly and provide further efficiency savings to our
customers.
Summary and outlook
A contract in Colombia, which has
been subject to short-term renewals for a number of years, is
expected to end during the first half of 2024. Although we are
disappointed with this outcome, we continue to see a strong
pipeline of opportunities across our many geographies, which will
help to replace this revenue stream in due course. The electronic
monitoring market remains supported by favourable tailwinds and a
continued global shift towards community-based
sentencing.
The Group is well-positioned, with
the financial flexibility to invest in new technologies, and has a
clear strategy for business development and investment in target
markets, where it is currently under-represented. Despite some
short-term headwinds to sales and profits in 2024, as a result of
the ending of the contract in Colombia, the Group expects to remain
highly profitable and cash-generative and we are excited about the
pipeline of future opportunities. The Board is confident of a
return to growth in 2025 and beyond.
Financial review
Revenue
Revenue increased by 10% to £55.2m
(2022: £50.2m) on an organic basis, driven by both new contract
wins and an increase in revenues earned from existing customers.
The second half of the year saw revenues increase to £27.9m for the
most recent six-month period (H1 2023: £27.3m) with the majority of
revenues continuing to be derived from customers in the criminal
justice sector, which accounts for more than 98% of reported
revenue (2022: 98%).
Revenue growth was driven by the
European and Asia-Pacific regions, which grew at 50% and 11%
respectively. Growth in Europe was primarily delivered by a new
government contract in the UK criminal justice sector awarded in
2022 which increased in volume during the year. The Group's
eight-year national monitoring contract with the New Zealand
Department of Corrections has now achieved its full run-rate and
was a key growth driver in Asia-Pacific. Revenue in the Americas
region declined by 4%.
The Group has been impacted by
adverse foreign currency movements in the year with sterling
strengthening against the US dollar, Australian dollar and New
Zealand dollar, the Group's main sales currencies. On a constant
currency basis, revenue would have been £1.6m higher than reported
if exchange rates had remained the same as the 2022 average. On a
constant currency basis, revenue increased by 13% versus last
year.
Monthly Recurring Revenue (MRR),
which is the exit run rate of monthly recurring revenue in the last
month of the financial year, was £4.1m (2022: £4.6m), a decrease of
11% due to the anticipated ending of a contract in South America
during the first half of 2024 which has been excluded from the MRR
figure. The MRR figure gives the Group visibility over its future
revenues derived from its long-term contracts.
Profitability
Gross profit increased by 7% to
£39.0m (2022: £36.4m), with gross margin decreasing by 180bps to
70.7% (2022: 72.5%) as a result of one-off charges in cost of sales
for higher inventory provisioning for previous generation
components (£0.7m) and an impairment loss recognised against other
fixed assets held by Buddi Colombia linked to the ending of a
customer contract in the country (£0.4m). Gross margin excluding
these one-off charges for higher inventory provisioning and
impairment of other fixed assets was 72.7%, up 20 bps on
2022.
The Group continues to report high
levels of gross profitability due to its scalable operating model,
which allows for the deployment of additional electronic monitoring
devices to customers with increased efficiency. Gross profits
earned on incremental revenues were able to offset increases in
labour, freight and manufacturing costs caused by the current
inflationary environment.
Adjusted operating profit of £28.2m
increased by 4% against 2022, with a decrease in adjusted operating
margin to 51.2% (2022: 54.1%). The largest driver for the decrease
was a less favourable foreign currency position compared with last
year when the Group benefitted from a one-off gain on the
revaluation of US Dollar denominated cash deposits. There were also
increases in labour costs during the year. Statutory operating
profit (which includes adjusting operating items and share-based
payments) decreased by 18% to £16.8m (2022: £20.6m).
Adjusted administrative expenses
(defined as administrative expenses before share-based payments and
amortisation of acquired intangible assets) increased by 17% from
£9.3m in 2022 to £10.8m in 2023. The largest driver for the
increase was a less favourable foreign currency position compared
with last year when the Group benefitted from a one-off gain on the
revaluation of US Dollar denominated cash deposits. The benefit
from foreign currency movements in 2023 was £0.4m (2022: £1.0m).
There were also increases in labour costs during the year.
Statutory administrative expenses (which includes adjusting
operating items and share-based payments) increased by 41% to
£22.2m (2022: £15.8m).
Finance income was £2.7m (2022:
£0.4m) and reflects the interest earned by the Group on its
significant cash balances held in interest bearing deposit accounts
and in money-market instruments. Finance expenses increased
slightly during the year due to interest recognised on newly
capitalised lease liabilities.
EBITDA
Adjusted EBITDA, which provides a
more consistent comparison of trading, year-on-year, increased by
8% to £33.0m (2022: £30.5m), with adjusted EBITDA margins falling
slightly by 90 bps to 59.8% (2022: 60.7%). Statutory EBITDA (which
includes share-based payments) decreased by 10% to £22.0m (2022:
£24.4m).
Taxation
The Group's total tax charge for the
year (including deferred taxes) was £1.8m (2022: £1.0m), an
effective tax rate of 9.2% (2022: 4.9%). The Group's tax and the
effective tax rate is affected by a number of factors including the
recognition of deferred tax assets in relation to share-based
payments and the tax deductibility of exercised employee share
awards. The Group also benefits from enhanced capital allowances,
allowances for R&D expenditure and the UK Patent Box. The
effective tax rate is lower than the current UK corporation tax
rate, but is expected to increase in future years. Deferred taxes
debited directly in equity totalled £0.4m (2022: £1.6m
credit).
Earnings per share
Adjusted diluted earnings per share
(EPS), which excludes adjusting items and their associated tax
effect as well as the dilutive impact of shares issuable in the
future, was 8.6p (2022: 8.1p), reflecting the increase in
underlying profitability of the Group. Adjusted basic EPS, which
excludes adjusting items and their associated tax effect was 9.2p
(2022: 8.6p). Diluted EPS, which includes the dilutive impact of
shares issuable in the future, was 5.7p (2022: 6.5p). Basic EPS was
6.1p (2022: 6.9p). The dilutive impact of shares issuable in the
future relates to the expected settlement of the Group's employee
share scheme obligations. Shares held by the Group's Employee
Benefit Trust are excluded on a weighted basis from the calculation
of EPS.
Cash
generation
The Group increased its net cash
balances (defined as cash and cash equivalents less lease
liabilities) to £85.9m (2022: £66.8m) at 31 December
2023.
The Group delivered strong cash flow
from operations (before the payment of taxes) of £31.7m (2022:
£25.7m) including a £1.6m (2022: £5.1m) net working capital
outflow. The cash conversion rate (defined as percentage of
adjusted EBITDA converted to cash from operations) increased from
84.4% to 96.2% of adjusted EBITDA. Taxation payments for the year
totalled £3.7m (2022: £1.8m).
Net cash utilised in investing
activities of £3.2m (2022: £5.1m) reflects the continued
expenditure on electronic monitoring devices, which are
manufactured in-house and leased to the Group's customers. The
Group continued to invest in research and development activities
and also benefitted from increased interest income, reflecting
interest earned on its cash balances at improving interest
rates.
Net cash used / (generated) from
financing activities of £4.5m (2022: £0.3m) reflects the purchase
of shares by the Employee Benefit Trust during the year and the
repayment of lease liabilities, offset by proceeds received from
the exercise of employee share options.
Research and development
Research and development (R&D)
activities remain a priority for the Group to ensure its products
retain their competitive advantage. Development costs of £1.1m
(2022: £1.1m) have been capitalised. Total R&D costs (including
those charged as an expense) expressed as a percentage of adjusted
administrative expenses stood at 31% (2022: 31%).
Foreign currency exposure
The
Group faces currency exposure on its foreign currency transactions
and translation exposure in relation to its overseas subsidiaries
and foreign currency sales. The Group maintains a natural hedge
whenever possible to transactional exposure by matching the cash
inflows and outflows in the respective currencies.
Foreign exchange translation has
provided a slight headwind for revenue and profit during the year
(2022: tailwind), with sterling strengthening against the Group's
main sales currencies compared with last year.
The Group's most material exposures
are to US dollars, Australian dollars and New Zealand dollars. The
sensitivity to a 10% weakening/strengthening of sterling against
these currencies in aggregate (excluding amounts held on the
balance sheet) equates to an annualised profit increase (or
decrease) of approximately £2.4m. The Group's forward currency
exposure is currently unhedged.
Alternative performance measures
In the analysis of the Group's
financial performance and position, operating results and cash
flows, alternative performance measures are presented to provide
readers with additional information. The principal measures
presented are adjusted measures of earnings including adjusted
operating profit, adjusted operating margin, adjusted profit before
tax, adjusted EBITDA and adjusted earnings per share.
The Annual Report includes both
statutory and adjusted non-GAAP financial measures, the latter of
which the Directors believe better reflect the underlying
performance of the business and provide a more meaningful
comparison of how the business is managed and measured on a
day-to-day basis. The Group's alternative performance measures and
KPIs are aligned to the Group's strategy and together are used to
measure the performance of the business and form the basis of the
performance measures for remuneration. Adjusted results exclude
certain items because, if included, these items could distort the
understanding of the performance for the year and the comparability
between periods.
We provide comparatives alongside
all current year figures. The term 'adjusted' is not defined under
IFRS and may not be comparable with similarly titled measures used
by other companies. All profit and earnings per share figures in
this Annual Report relate to underlying business performance (as
defined above) unless otherwise stated.
A reconciliation of adjusted
measures to statutory measures is provided below:
|
2023
|
|
2022
|
|
Statutory
|
Adjustments
|
Adjusted
|
|
Statutory
|
Adjustments
|
Adjusted
|
|
|
|
|
|
|
|
|
Operating profit (£'000)
|
16,813
|
11,436
|
28,249
|
|
20,590
|
6,524
|
27,114
|
Operating margin (%)
|
30.4
|
20.8
|
51.2
|
|
41.0
|
13.1
|
54.1
|
Administrative expenses
(£'000)
|
22,246
|
(11,436)
|
10,810
|
|
15,800
|
(6,524)
|
9,276
|
Profit before tax (£'000)
|
19,374
|
11,436
|
30,810
|
|
20,995
|
6,524
|
27,519
|
Taxation (£'000)
|
1,792
|
2,392
|
4,184
|
|
1,033
|
1,641
|
2,674
|
Profit after tax (£'000)
|
17,582
|
9,044
|
26,626
|
|
19,962
|
4,883
|
24,845
|
EBITDA (£'000)
|
22,037
|
10,968
|
33,005
|
|
24,409
|
6,056
|
30,465
|
EBITDA margin (%)
|
39.9
|
19.9
|
59.8
|
|
48.6
|
12.1
|
60.7
|
Cash generated from operating
activities (£'000)
|
31,748
|
-
|
31,748
|
|
25,725
|
-
|
25,725
|
Basic earnings per share
(pence)
|
6.1
|
3.1
|
9.2
|
|
6.9
|
1.7
|
8.6
|
Diluted earnings per share
(pence)
|
5.7
|
2.9
|
8.6
|
|
6.5
|
1.6
|
8.1
|
The adjustments comprise:
|
2023
£'000
|
2022
£'000
|
Amortisation of acquired
intangibles
|
468
|
468
|
Total adjusting operating items
|
468
|
468
|
Share-based payments
expense
|
10,968
|
6,056
|
Total adjusting items and share-based payments before
tax
|
11,436
|
6,524
|
Tax effect of adjusting items and
share-based payments
|
(2,392)
|
(1,641)
|
Total adjusting items and share-based payments after
tax
|
9,044
|
4,883
|
Amortisation of acquired intangibles
These costs are excluded from the
adjusted results of the Group since the costs are non-cash charges
arising from investment activities. As such, they are not
considered reflective of the core trading performance of the
Group.
Share-based payments expense
These costs are excluded from the
adjusted results of the Group since the costs are non-cash charges
arising from recognition of the fair value of share options and
other share-based incentives granted to employees of the Group. As
such, they are not considered reflective of the core trading
performance of the Group.
Tax
effect of adjusting items and share-based
payments
The tax impact of these adjustments
was as follows: amortisation of acquired intangibles of £0.1m
(2022: £0.1m) and share-based payments expense of £2.3m (2022:
£1.6m).
Balance sheet highlights
The Group has continued to
strengthen its balance sheet during the year with net assets
increasing from £102.5m to £125.7m at the 31 December
2023.
Current assets increased by £19.7m
to £103.3m, mainly due to a £20.3m increase in cash and cash
equivalents driven by the strong underlying trading performance in
the year and more favourable working capital movement. Trade and
other receivables decreased by £0.9m, driven by a reduction in
trade receivables due to quicker cash collection, with debtor days
(calculated using annualised December revenue) now at 44 days
(2022: 50 days). Inventories increased by £0.4m with the Group
holding adequate levels of inventory to support customers during
2024. Some previous generation components in inventory were
provided for during the year.
Non-current assets increased by
£2.0m to £31.7m, mainly due to increases in property, plant and
equipment and deferred tax assets, offset by a reduction in other
receivables. Property, plant and equipment increased by £0.8m, due
to continued expenditure on electronic monitoring devices to
support revenue growth in the year, offset by depreciation and a
one-off impairment charge. Deferred tax assets increased by £1.6m,
due to the continued recognition of balances related to the
share-based payment arrangements through the income statement with
a partial reversal in equity. Other receivables decreased by
£1.1m.
Current liabilities decreased by
£2.1m to £7.1m, mainly due to a decrease in trade payables and
contract liabilities. Non-current liabilities increased by £0.6m to
£2.1m, mainly due to an increase in lease liabilities as a result
of new leases entered into during the year.
Litigation
During the year, legal proceedings
have commenced against the Group, with an amended claim being filed
with the High Court of Justice in England and Wales in November
2023. As set out within the admission document in July 2021 (the
"Admission Document"), a letter of potential claim had been
received from a small number of former shareholders of Buddi
Limited, one of the subsidiaries of the Group, in respect of the
acquisition of Buddi Limited, dating back to May 2018. The Group
has taken advice from its lawyers and from King's Counsel and
remains of the view that the claim lacks legal and factual merit
and intends to defend its position robustly.
Financial outlook
The Group is well-positioned with
the financial flexibility to invest in new technologies and has a
clear strategy for business development and investment in target
markets, where it is currently under-represented. Despite some
short-term headwinds to sales and profits in 2024 as a result of
the ending of the contract in Colombia, the Group expects to remain
highly profitable and cash-generative and we are excited about the
pipeline of future opportunities. The Board is confident of a
return to growth in 2025 and beyond.
Directors' Responsibility Statement on the Annual Report and
Accounts
The responsibility statement below
has been prepared in connection with the Group's full annual report
and accounts for the year ended 31 December 2023. Certain parts
thereof are not included within this preliminary
announcement.
The Directors are responsible for
preparing the Strategic Report, the Directors' Report, any other
surrounding information and the Group and Parent Company financial
statements in accordance with applicable law and regulations.
Company law requires the Directors to prepare Group and Parent
Company financial statements for each financial year. Under that
law, they have elected to prepare the Group financial statements in
accordance with UK adopted International Accounting Standards and
applicable law and have elected to prepare the Parent Company
financial statements in accordance with UK Accounting Standards and
applicable law (UK Generally Accepted Accounting Practice). Under
Company law, the Directors must not approve the financial
statements unless they are satisfied that they give a true and fair
view of the state of affairs of the Group and Parent Company and of
their profit or loss for that year. In preparing each of the Group
and Parent Company financial statements, the Directors are required
to:
· select
suitable accounting policies and apply them
consistently;
· make
judgements and accounting estimates that are reasonable and
prudent;
· state
whether applicable accounting standards have been followed, subject
to any material departures disclosed and explained in the financial
statements; and
· prepare the financial statements on the going concern basis
unless it is inappropriate to presume that the Group and the Parent
Company will continue in business.
The Directors are responsible for
keeping adequate accounting records that are sufficient to show and
explain the Parent Company's transactions and disclose with
reasonable accuracy at any time the financial position of the
Parent Company and enable them to ensure that the financial
statements comply with the Companies Act 2006. They are also
responsible for safeguarding the assets of the Parent Company and
hence for taking reasonable steps for the prevention and detection
of fraud and other irregularities. They are further responsible for
ensuring that the Strategic Report and the Report of the Directors
and other information included in the Annual Report and Accounts is
prepared in accordance with applicable law in the United Kingdom.
The maintenance and integrity of the Big Technologies plc website
is the responsibility of the Directors; the work carried out
by the auditor does not involve the consideration of these
matters and, accordingly, the auditor accepts no responsibility for
any changes that may have occurred in the accounts since they
were initially presented on the website. Legislation in the
United Kingdom governing the preparation and dissemination of the
accounts and the other information included in Annual Reports may
differ from legislation in other jurisdictions.
This responsibility statement was
approved by the Board of Directors on 25 March 2024 and is signed
on its behalf by Sara Murray and Daren Morris.
Consolidated statement of comprehensive
income
For
the year ended 31 December 2023
|
Note
|
2023
£'000
|
|
2022
£'000
|
Revenue
|
2
|
55,223
|
|
50,164
|
Cost of sales
|
|
(16,176)
|
|
(13,781)
|
Gross profit
|
|
39,047
|
|
36,383
|
Administrative expenses
|
|
(22,246)
|
|
(15,800)
|
Other operating income
|
|
12
|
|
7
|
Operating profit
|
|
16,813
|
|
20,590
|
Analysed as:
|
|
|
|
|
Adjusted EBITDA
|
|
33,005
|
|
30,465
|
Amortisation of acquired
intangibles
|
|
(468)
|
|
(468)
|
Amortisation of development
costs
|
|
(921)
|
|
(806)
|
Depreciation
|
|
(3,835)
|
|
(2,545)
|
Share-based payments
expense
|
8
|
(10,968)
|
|
(6,056)
|
Operating profit
|
|
16,813
|
|
20,590
|
Finance income
|
|
2,656
|
|
449
|
Finance expenses
|
|
(95)
|
|
(42)
|
Share of loss of joint
venture
|
|
-
|
|
(2)
|
Profit before taxation
|
|
19,374
|
|
20,995
|
Taxation
|
4
|
(1,792)
|
|
(1,033)
|
Profit for the year
|
|
17,582
|
|
19,962
|
|
|
|
|
|
|
|
|
|
|
Other comprehensive (expense) /
income:
|
|
|
|
|
Exchange differences on translation
of foreign operations
|
|
(663)
|
|
139
|
Total comprehensive income for the
year
|
|
16,919
|
|
20,101
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Basic earnings per share
(pence)
|
|
6.1p
|
|
6.9p
|
Diluted earnings per share
(pence)
|
|
5.7p
|
|
6.5p
|
Consolidated statement of financial position
As
at 31 December 2023
|
Note
|
2023
£'000
|
|
2022
£'000
|
Assets
|
|
|
|
|
Goodwill
|
|
13,359
|
|
13,359
|
Acquired and other intangible
assets
|
|
5,668
|
|
6,000
|
Property, plant and
equipment
|
|
4,993
|
|
4,178
|
Right-of-use assets
|
|
1,782
|
|
705
|
Deferred tax assets
|
|
5,310
|
|
3,725
|
Other receivables
|
|
583
|
|
1,684
|
Non-current assets
|
|
31,695
|
|
29,651
|
|
|
|
|
|
Inventories
|
|
7,206
|
|
6,823
|
Trade and other
receivables
|
|
8,328
|
|
9,222
|
Cash and cash equivalents
|
6
|
87,729
|
|
67,474
|
Current assets
|
|
103,263
|
|
83,519
|
Total assets
|
|
134,958
|
|
113,170
|
|
|
|
|
|
Liabilities
|
|
|
|
|
Lease liabilities
|
|
274
|
|
247
|
Trade and other payables
|
|
6,146
|
|
8,153
|
Provisions
|
|
664
|
|
800
|
Current liabilities
|
|
7,084
|
|
9,200
|
|
|
|
|
|
Lease liabilities
|
|
1,579
|
|
460
|
Deferred tax liabilities
|
|
302
|
|
412
|
Trade and other payables
|
|
259
|
|
625
|
Non-current liabilities
|
|
2,140
|
|
1,497
|
Total liabilities
|
|
9,224
|
|
10,697
|
|
|
|
|
|
Net assets
|
|
125,734
|
|
102,473
|
|
|
|
|
|
Equity
|
|
|
|
|
Share capital
|
7
|
2,907
|
|
2,904
|
Share premium
|
7
|
39,095
|
|
39,031
|
Employee Benefit Trust
reserve
|
|
(4,276)
|
|
-
|
Other reserves
|
|
(249)
|
|
414
|
Retained earnings
|
|
88,257
|
|
60,124
|
Total equity
|
|
125,734
|
|
102,473
|
Consolidated statement of changes in equity
For
the year ended 31 December 2023
|
Share capital
£'000
|
Share premium
£'000
|
EBT
reserve
£'000
|
Other reserves
£'000
|
Retained earnings
£'000
|
Total
equity
£'000
|
Balance at 1 January 2022
|
2,885
|
38,535
|
-
|
275
|
32,536
|
74,231
|
Profit for the year
|
-
|
-
|
-
|
-
|
19,962
|
19,962
|
Other comprehensive income for the
year
|
-
|
-
|
-
|
139
|
-
|
139
|
Total comprehensive income for the
year
|
-
|
-
|
-
|
139
|
19,962
|
20,101
|
|
|
|
|
|
|
|
Share-based payments
|
-
|
-
|
-
|
-
|
6,026
|
6,026
|
Deferred tax on share-based
payments
|
-
|
-
|
-
|
-
|
1,600
|
1,600
|
Issue of shares, net of share issue
costs
|
19
|
496
|
-
|
-
|
-
|
515
|
Balance at 31 December
2022
|
2,904
|
39,031
|
-
|
414
|
60,124
|
102,473
|
|
|
|
|
|
|
|
Balance at 1 January 2023
|
2,904
|
39,031
|
-
|
414
|
60,124
|
102,473
|
Profit for the year
|
-
|
-
|
-
|
-
|
17,582
|
17,582
|
Other comprehensive income for the
year
|
-
|
-
|
-
|
(663)
|
-
|
(663)
|
Total comprehensive income for the
year
|
-
|
-
|
-
|
(663)
|
17,582
|
16,919
|
|
|
|
|
|
|
|
Share-based payments
|
-
|
-
|
-
|
-
|
10,951
|
10,951
|
Deferred tax on share-based
payments
|
-
|
-
|
-
|
-
|
(400)
|
(400)
|
Issue of shares, net of share issue
costs
|
3
|
64
|
-
|
-
|
-
|
67
|
Purchase of shares by the
EBT
|
-
|
-
|
(4,276)
|
-
|
-
|
(4,276)
|
Balance at 31 December
2023
|
2,907
|
39,095
|
(4,276)
|
(249)
|
88,257
|
125,734
|
Consolidated statement of cash flows
For
the year ended 31 December 2023
|
Note
|
2023
£'000
|
|
2022
£'000
|
Cash flows from operating
activities
|
|
|
|
|
Profit before tax
|
|
19,374
|
|
20,995
|
Adjustments for:
|
|
|
|
|
Depreciation of property, plant and
equipment
|
|
3,595
|
|
2,328
|
Depreciation of right-of-use
assets
|
|
240
|
|
217
|
Amortisation of intangible
assets
|
|
1,389
|
|
1,274
|
Impairment charges on property, plant
and equipment
|
|
392
|
|
-
|
Share of loss of joint
venture
|
|
-
|
|
2
|
Investment write-down
|
|
-
|
|
426
|
Share-based payments
expense
|
8
|
10,951
|
|
6,026
|
Finance income
|
|
(2,656)
|
|
(449)
|
Finance expenses
|
|
95
|
|
42
|
Changes in:
|
|
|
|
|
Inventories
|
|
(383)
|
|
(3,744)
|
Trade and other
receivables
|
|
2,405
|
|
(2,986)
|
Trade and other payables
|
|
(3,518)
|
|
794
|
Provisions
|
|
(136)
|
|
800
|
Cash generated from operating
activities
|
|
31,748
|
|
25,725
|
Taxes paid
|
|
(3,739)
|
|
(1,801)
|
Net cash generated from operating
activities
|
|
28,009
|
|
23,924
|
|
|
|
|
|
Cash flows from investing
activities
|
|
|
|
|
Purchase of property, plant and
equipment
|
|
(508)
|
|
(142)
|
Own work capitalised
|
|
(4,303)
|
|
(4,098)
|
Capitalised development
costs
|
|
(1,057)
|
|
(1,132)
|
Interest received
|
|
2,569
|
|
295
|
Net cash used in investing
activities
|
|
(3,299)
|
|
(5,077)
|
|
|
|
|
|
Cash flows from financing
activities
|
|
|
|
|
Proceeds from issues of
shares
|
|
67
|
|
515
|
Purchase of own shares
|
|
(4,276)
|
|
-
|
Repayment of lease
liabilities
|
|
(240)
|
|
(238)
|
Interest paid
|
|
(35)
|
|
(25)
|
Net cash (used) / generated from
financing activities
|
|
(4,484)
|
|
252
|
|
|
|
|
|
Net increase in cash and cash
equivalents
|
|
20,226
|
|
19,099
|
Cash and cash equivalents at the
beginning of the year
|
|
67,474
|
|
48,317
|
Effects of exchange rate changes on
cash and cash equivalents
|
|
29
|
|
58
|
Cash and cash equivalents at the end
of the year
|
6
|
87,729
|
|
67,474
|
Notes to the consolidated financial
statements
For
the year ended 31 December 2023
1. General information and basis of
preparation
Big Technologies plc is a public
limited company incorporated in the United Kingdom, listed on the
Alternative Investment Market ('AIM') of the London Stock Exchange.
The Company is domiciled in the United Kingdom and its registered
office is Talbot House, 17 Church Street, Rickmansworth, WD3 1DE.
The consolidated financial statements comprise the Company and its
subsidiaries (together referred to as the 'Group').
The principal activity of the Group
is the development and delivery of remote monitoring technologies
and services to a range of domestic and international
customers.
The preliminary announcement for the
year ended 31 December 2023 has been prepared in accordance with
the accounting policies as disclosed in the Group's annual
financial statements for the year ended 31 December 2022.
Information in this preliminary announcement does not constitute
statutory accounts of the Group within the meaning of section 434
of the Companies Act 2006.
The annual financial information
presented in this preliminary announcement is based on, and is
consistent with, that in the Group's audited financial statements
for the year ended 31 December 2023, and those financial statements
will be delivered to the Registrar of Companies following the
Company's Annual General Meeting. The financial statements of the
Group are prepared in accordance with UK-adopted international
accounting standards and applicable law. The independent auditors'
report on those financial statements is unqualified and does not
contain any statement under section 498 (2) or 498 (3) of the
Companies Act 2006.
Going concern
The Group's financial statements
have been prepared on the going concern basis, which contemplates
the continuity of normal business activity and the realisation of
assets and the settlement of liabilities in the normal course of
business.
The Directors have reviewed the
forecasts for the Group for the period to 31 December 2026 and have
a reasonable expectation that there are no material uncertainties
that cast significant doubt about the Group's ability to continue
in operational existence for at least 12 months from the date of
signing these financial statements. Accordingly, they continue to
adopt the going concern basis in preparing the consolidated
financial statements.
This preliminary announcement was
approved by the Board of Directors on 25 March 2024.
2. Segment reporting
The Group derives revenue from the
delivery of remote monitoring technologies and services to a range
of domestic and international customers.
The income streams are all derived
from the utilisation of these products and services which, in all
aspects except details of revenue, are reviewed and managed
together within the Group and as such are considered to be the only
segment. The Group operates across three regions: Europe,
Asia-Pacific and the Americas, and the Board of Directors monitors
revenue on this basis.
Revenue for each of the geographical
areas is as follows:
|
2023
£'000
|
|
2022
£'000
|
|
|
|
|
Europe
|
7,555
|
|
5,048
|
Asia-Pacific
|
32,289
|
|
29,165
|
Americas
|
15,379
|
|
15,951
|
|
55,223
|
|
50,164
|
Assets and liabilities by segment
are not regularly reviewed by the Board of Directors on a monthly
basis and are not used as key decision-making tools and are
therefore not disclosed here.
Revenues are disaggregated as
follows:
|
2023
£'000
|
|
2022
£'000
|
|
|
|
|
Sales of goods
|
97
|
|
97
|
Delivery of services
|
55,126
|
|
50,067
|
|
55,223
|
|
50,164
|
Information about major customers
Three (2022: three) of the Group's
customers individually account for more than 10% of total Group
revenue. These customers operate in the criminal justice sector and
account for 55% (2022: 51%) of total Group revenue.
Future performance obligations
The amount of a customer contract's
transaction price that is allocated to the remaining performance
obligations to provide electronic monitoring software, hardware and
related support services which has not yet been recognised.
Including amounts recognised as contract liabilities and amounts
that are contracted but not yet delivered. The transaction price
allocated to these performance obligations that are unsatisfied or
partially unsatisfied as of 31 December 2023 is £12,166,000 (2022:
£14,791,000).
Management expects that £7,791,000
in 2023 (2022: £6,125,000) of the amount allocated to the future
performance obligations as of 31 December 2023 will be recognised
during 2024. £4,375,000 (2022: £8,666,000) is expected to be
recognised as revenue within two to five years. The Group applies
the practical expedient in paragraph 121 of IFRS 15 and does not
disclose information about remaining performance obligations that
have original expected durations of one year or less.
3. Alternative performance
measures
These items are included in normal
operating costs of the business, but are significant cash and
non-cash expenses that are separately disclosed because of their
size, nature or incidence. It is the Group's view that excluding
them from operating profit gives a better representation of the
underlying performance of the business in the year.
|
2023
£'000
|
|
2022
£'000
|
|
|
|
|
Amortisation of acquired
intangibles
|
468
|
|
468
|
Total adjusting operating items
|
468
|
|
468
|
Share-based payments
expense
|
10,968
|
|
6,056
|
Total adjusting items and share-based payments before
tax
|
11,436
|
|
6,524
|
Tax effect of adjusting items and
share-based payments
|
(2,392)
|
|
(1,641)
|
Total adjusting items and share-based payments after
tax
|
9,044
|
|
4,883
|
Amortisation of acquired intangibles
These costs are excluded from the
adjusted results of the Group since the costs are non-cash charges
arising from investment activities. As such, they are not
considered reflective of the core trading performance of the
Group.
Share-based payments expense
These costs are excluded from the
adjusted results of the Group since the costs are non-cash charges
arising from recognition of the fair value of share options and
other share-based incentives granted to employees of the Group. As
such, they are not considered reflective of the core trading
performance of the Group.
Tax
effect of adjusting items and share-based
payments
The tax impact of these adjustments
was as follows: amortisation of acquired intangibles of £110,000
(2022: £89,000) and share-based payments expense of £2,282,000
(2022: £1,552,000).
4. Taxation
|
2023
£'000
|
|
2022
£'000
|
Current tax
|
|
|
|
For the financial year
|
3,673
|
|
2,218
|
Adjustments in respect of prior
years
|
217
|
|
(13)
|
|
3,890
|
|
2,205
|
Deferred tax
|
|
|
|
Origination and reversal of
temporary timing differences
|
184
|
|
389
|
Adjustments in respect of prior
years
|
-
|
|
(9)
|
Related to share-based
payments
|
(2,282)
|
|
(1,552)
|
|
(2,098)
|
|
(1,172)
|
|
|
|
|
Total taxation for the year
|
1,792
|
|
1,033
|
|
|
|
|
UK corporation tax is calculated at
23.5% (2022: 19.0%) of the assessable profit for the year. Taxation
for other jurisdictions is calculated at the rates prevailing in
the respective jurisdictions.
5. Earnings per share
The calculation of the basic and
diluted earnings per share is based on the following
data:
|
2023
£'000
|
|
2022
£'000
|
|
|
|
|
|
|
|
|
Profit for the purpose of basic and
diluted earnings per share
|
17,582
|
|
19,962
|
|
|
|
|
Adjustments for:
|
|
|
|
Adjusting items
|
468
|
|
468
|
Share-based payments
expense
|
10,968
|
|
6,056
|
Tax effect of adjusting items and
share-based payments
|
(2,392)
|
|
(1,641)
|
|
|
|
|
Adjusted earnings
|
26,626
|
|
24,845
|
|
|
|
|
|
2023
No. shares
|
|
2022
No. shares
|
|
|
|
|
Weighted average number of ordinary
shares
|
290,531,356
|
|
289,950,953
|
Less shares held by the Employee
Benefit Trust (weighted average)
|
(416,300)
|
|
-
|
Weighted average number of ordinary
shares for the purpose of basic earnings per share
|
290,115,056
|
|
289,950,953
|
Effect of dilutive potential
Ordinary shares/share options
|
19,840,468
|
|
16,800,389
|
Weighted average number of Ordinary shares for the purpose of
diluted earnings per share
|
309,955,524
|
|
306,751,342
|
|
|
|
|
Basic earnings per share
|
2023
Pence
|
|
2022
Pence
|
|
|
|
|
Basic earnings per share
|
6.1
|
|
6.9
|
Adjustments for:
|
|
|
|
Adjusting items
|
0.2
|
|
0.2
|
Share-based payments
expense
|
3.8
|
|
2.1
|
Tax effect of adjusting items and
share-based payments
|
(0.9)
|
|
(0.6)
|
Adjusted basic earnings per share
|
9.2
|
|
8.6
|
Diluted earnings per share
|
2023
Pence
|
|
2022
Pence
|
|
|
|
|
Diluted earnings per
share
|
5.7
|
|
6.5
|
Adjustments for:
|
|
|
|
Adjusting items
|
0.2
|
|
0.2
|
Share-based payments
expense
|
3.5
|
|
2.0
|
Tax effect of adjusting items and
share-based payments
|
(0.8)
|
|
(0.6)
|
Adjusted diluted earnings per share
|
8.6
|
|
8.1
|
The adjusted earnings per share have
been calculated on the basis of profit before adjusting items and
share-based payments, net of tax. The tax effect of adjusting items
and share-based payments is equal to the deferred tax charge (or
credit) recognised in the consolidated income statement for these
items. The Directors consider that this calculation gives a better
understanding of the Group's earnings per share in the current and
prior year.
6. Cash and cash equivalents
The carrying amounts of the cash and
cash equivalents are denominated in the following
currencies:
|
2023
£'000
|
|
2022
£'000
|
|
|
|
|
Pounds Sterling
|
53,831
|
|
58,386
|
US Dollar
|
6,105
|
|
3,389
|
Australian Dollar
|
13,760
|
|
2,480
|
New Zealand Dollar
|
11,420
|
|
2,674
|
Colombian Peso
|
1,627
|
|
318
|
Euro
|
438
|
|
20
|
Canadian Dollar
|
342
|
|
126
|
Other
|
206
|
|
81
|
|
87,729
|
|
67,474
|
£203,000 (2022: £nil) of the Group's
cash and cash equivalents are held by the trustees of the Big
Technologies PLC Employee Benefit Trust in Pounds
Sterling.
Net
cash
|
2023
£'000
|
|
2022
£'000
|
|
|
|
|
Cash and cash equivalents
|
87,729
|
|
67,474
|
Lease liabilities
|
(1,853)
|
|
(707)
|
|
85,876
|
|
66,767
|
|
|
|
|
7. Share capital
The allotted, called up and fully paid share capital is made up of
290,650,082 ordinary shares of £0.01 each.
|
Note
|
Number
of
shares
|
Share
capital
|
Share
premium
|
Total
|
|
|
|
£'000
|
£'000
|
£'000
|
|
|
|
|
|
|
At 1 January 2022
|
|
288,505,082
|
2,885
|
38,535
|
41,420
|
Issue of shares
|
(i)
|
1,895,000
|
19
|
496
|
515
|
At
31 December 2022
|
|
290,400,082
|
2,904
|
39,031
|
41,935
|
|
|
|
|
|
|
Issue of shares
|
(ii)
|
250,000
|
3
|
64
|
67
|
At 31 December 2023
|
|
290,650,082
|
2,907
|
39,095
|
42,002
|
(i) During 2022, 1,795,000 EMI share
options and 100,000 non-EMI share options were exercised into
shares with a nominal value of £0.01 each for £0.27 and £0.34
respectively.
(ii) During 2023, 250,000 EMI share
options were exercised into shares with a nominal value of £0.01
each for £0.27.
8. Share-based payments
The Group has a number of
equity-settled share-based payment arrangements in operation, the
details of which are disclosed in the 2023 Annual Report. The
schemes were established to reward and incentivise the senior
management team and employees to deliver share price
growth.
The charge made in respect of
share-based payments is as follows:
|
2023
£'000
|
|
2022
£'000
|
|
|
|
|
Non-EMI Plan (Chair)
|
51
|
|
112
|
LTIP
|
267
|
|
145
|
Growth Share Plan
|
10,633
|
|
5,769
|
Share-based payments expense (IFRS 2 charge)
|
10,951
|
|
6,026
|
Employers' tax charge in relation to
share awards
|
17
|
|
30
|
Total charge in respect of share-based
payments
|
10,968
|
|
6,056
|
|
|
|
|
9. Principal risks and
uncertainties
The principal risks and uncertainties impacting the Group are
described in the 2023 Annual Report. They include: reliance on key
customers, failure to manage growth, change in government policy,
failure to develop new products, competitor actions, reliance on
third-party technology and communication systems, reputational
risk, dependence on partners, loss of key personnel, supply chain,
product liability, foreign exchange risk, credit risk, business
taxation, bid pricing, cyber security/business interruption,
intellectual property/patents and operating in global
markets.
10. Related party transactions
Transactions between the Company and
its subsidiaries, which are related parties, have been eliminated
on consolidation and are not disclosed in this section of the
notes.
The Group's other related party
transactions were the remuneration of key management personnel.
Details of Directors' remuneration for the year are provided in the
Remuneration Committee Report in the 2023 Annual Report.
In addition to these transactions,
£100,000 (2022: £100,000) was paid to TFM Developments Ltd, a
company of which Sara Murray is a director. The transaction relates
to a licence fee paid in respect of a patent owned by the company
used by the Group as part of its continuing research and
development activities.